What is the share price of Gland Pharma Limited?
Get GLAND share value with Latest News, Volume
Breakout, Delivery Volume Percentage, Pivot Levels,
Fibonacci Levels, Camarilla levels and Candlestick
Patterns. Company shares prices keep fluctuating as
per market conditions. There may be many reasons for
the rise and fall of the share price of stocks. It may
be market conditions, it may be sector & industry
reasons and it may be stocks itself like earnings,
order, upgrade or downgrade etc. GLAND share
value today is ₹1752
24 Apr, 2024 | 03:32PM
What is the Market cap of Gland Pharma Limited?
The Market Cap of Gland Pharma Limited is
₹28985 Cr As on
24 Apr, 2024 | 03:32PM. Market capitalization,
or market cap, is the total value of a company's
shares of stock. It is one measurement of a company's
size. A high market cap signifies that the company has
a larger presence in the market. Larger companies may
have less growth potential compares to start-up firms.
Market capitalization refers to how much a company is
worth as determined by the stock market. It is defined
as the total market value of all outstanding shares.
To calculate a company's market cap, multiply the
number of outstanding shares by the current market
value of one share.
What is the PE ratio of Gland Pharma Limited?
The P/E ratio of Gland Pharma Limited is
43.92 As on
24 Apr, 2024 | 03:32PM. Price to Earnings Ratio
or Price to Earnings Multiple is the ratio of share
price of a stock to its earnings per share (EPS). PE
ratio is one of the most popular valuation metric of
stocks. Typically, the average P/E ratio is around 20
to 25. In general, a high P/E suggests that investors
are expecting higher earnings growth in the future
compared to companies with a lower P/E. A low P/E can
indicate either that a company may currently be
undervalued or that the company growth has stagnant
due to its matured stage.
What is the 52-week high and 52-week low of Gland
Pharma Limited?
A 52 week high of Gland Pharma Limited is
₹2194 while 52 week low is ₹861. A 52
week high, as the name suggests, is the highest price
that the security/stock has traded over a 52 week
period i.e. a year. Similarly 52 week low is the
lowest price that stock has traded over a 52 week
period. It is a technical indicator that is used to
analyse the security's current price. The 52 week high
and 52 week low are also used to predict future
movements as well. 52 week is bullish signal and 52
week low is bearish signal.
What is Support price of Gland Pharma Limited?
First support of Gland Pharma Limited is
₹1768.70
Second support of
Gland Pharma Limited is ₹1752.40
Third support of Gland Pharma Limited is
₹1743.75
Traders use support to plan
entry. Support is the level at which demand is strong
enough to stop the stock from falling any further.
Support is specific point on chart at which maximum
buiying occurs.
What is Resistance price of Gland Pharma Limited?
First resistance of Gland Pharma Limited is
₹1793.65
Second resistance of
Gland Pharma Limited is ₹1802.30
Third resistance of
Gland Pharma Limited is ₹1818.60
Traders use resistance to plan exit of trade.
Resistance is the level at which selling is strong
enough to stop the stock from moving up any further.
Resistance is specific point on chart at which maximum
selling occurs.
What is Gland Pharma Limited share price target 2024?
First target of Gland Pharma Limited is
₹1898.40
Second target of
Gland Pharma Limited is ₹1966.80
Third target of Gland Pharma Limited is
₹2082.60
What is Gland Pharma Limited share price target 2025?
First target of Gland Pharma Limited is ₹2347.16
Second target of Gland Pharma Limited is
₹2480.59
Third target of
Gland Pharma Limited is ₹2612.41
What is Gland Pharma Limited share price history?
Date |
Open |
High |
Low |
Close |
Volume |
%Chg |
2024-04-22 |
1784 |
1784 |
1753 |
1776.9 |
86990 |
0.65 |
2024-04-19 |
1740.05 |
1779.7 |
1736 |
1763.6 |
96212 |
0.04 |
2024-04-18 |
1750 |
1778 |
1732 |
1764.4 |
346803 |
0.76 |
2024-04-16 |
1749 |
1768.5 |
1731.7 |
1749.75 |
187181 |
-0.13 |
2024-04-15 |
1731.6 |
1759 |
1711.8 |
1752.3 |
335718 |
0.11 |
2024-04-12 |
1776.2 |
1781.35 |
1735 |
1749.65 |
840422 |
-2.67 |
2024-04-10 |
1809.65 |
1812.7 |
1771 |
1792.4 |
521014 |
-0.29 |
2024-04-08 |
1789.95 |
1879 |
1768.1 |
1859.6 |
845548 |
6.57 |
2024-04-05 |
1780.05 |
1799.95 |
1745 |
1754.55 |
127185 |
-0.87 |
2024-04-04 |
1810 |
1810 |
1770.05 |
1775.1 |
130476 |
-0.76 |
Historical share price of stock is needed to find
the trend of stock, performance analysis of stock
price. History of share price is also used to find
the demand and supply by analyzing volume data if
available.
What is the ROE (Return on Equity) of Gland Pharma
Limited?
The ROE of Gland Pharma Limited is
10.33% . Return on equity (ROE) is the measure
of a company's net income divided by its shareholders'
equity. ROE is a gauge of a corporation's
profitability and how efficiently it generates those
profits. The higher the ROE, the better a company. A
return on equity ratio of 15% to 20% is usually
considered good. ROE is a gauge of a corporation's
profitability and how efficiently it generates those
profits.
What is the Earning per Share (EPS) of Gland Pharma
Limited?
The EPS of Gland Pharma Limited is
₹39.98. Earnings per share (EPS) is a company's
net profit divided by the number of common shares it
has outstanding. EPS indicates how much money a
company makes for each share of its stock. There's no
fixed answer for what is a good EPS. When comparing
companies, it's helpful to look closely at how EPS is
trending and how it matches up to competitor earnings.
Remember that a higher EPS can suggest growth and
stock price increases.
What is the ROCE of Gland Pharma Limited?
The ROCE of Gland Pharma Limited is
13.20%. Return on capital employed is a
financial ratio that measures a company's
profitability in terms of all of its capital. ROCE is
similar to return on invested capital. It's always a
good idea to compare the ROCE of companies in the same
industry. The higher the ROCE, the better it is. The
ratio calculated as 20% is considered good, indicating
the company is more profitable and has a stable
financial position in the market.
What is the NPM (Net profit margin) of Gland Pharma
Limited?
The NPM of Gland Pharma Limited is
20.21%. Net Profit Margin is a financial ratio
used to calculate the percentage of profit a company
produces from its total revenue. Net profit margin
helps investors assess if a company's management is
generating enough profit from its sales and whether
operating costs and overhead costs are under control.
What is EBITDA of Gland Pharma Limited?
The EBITDA of Gland Pharma Limited is
31.27%. EBITDA stands for Earnings Before
Interest, Taxes, Depreciation, and Amortization. It is
the alternate method of measuring profitability in net
income. EBITDA is useful when comparing companies with
different capital investment, debt, and tax
profiles.This key profitability measure is one of the
main measures of a company's financial health and
ability to generate cash. It is one of the most widely
used measures of a company's financial health and
ability to generate cash.
What is Debt to Equity ratio (D/E Ratio) of Gland
Pharma Limited?
The debt to equity ratio of
Gland Pharma Limited is 0.06. The
debt-to-equity ratio (D/E ratio) shows how much debt a
company has compared to its assets. It is found by
dividing a company's total debt by total shareholder
equity. Generally, a good debt to equity ratio is
around 1 to 1.5. However, the ideal debt to equity
ratio will vary depending on the industry, as some
industries use more debt financing than others. A
higher D/E ratio means the company may have a harder
time covering its liabilities. It will be very hard if
the economic scenario worsens.
What is Gland Pharma Limited news today?
Gland Pharma Limited share news :
LTP 1752
%Chg: -1.68
Chg: -29.9
Volume: 85172
Get detailed Gland Pharma Limited share price
news, analysis, Dividend, Quarterly results,
Fundamentals & more information.
Today’s Gland Pharma Limited screener scan?
Get the last 5 days of Gland Pharma Limited share
screener at "ALL SCAN" feature of Money Tree Robo with
recommended price for buying & selling. Also find the
trend of Gland Pharma Limited share price screener
after recommendation.
What is Gland Pharma Limited share price target?
Gland Pharma Limited share price target today:
First target of Gland Pharma Limited share is
₹1814.11.
Second target of Gland Pharma Limited share is
₹1816.19.
Third target of Gland Pharma Limited share is
₹1822.43.